Skip to search formSkip to main contentSkip to account menu

U 62066

Known as: U-62,066E, U62,066E 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

spiradoline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Effects of a kappa agonist, spiradoline mesylate (U62,066E), on activation and vaginocervical-stimulation produced analgesia in rats
1999
1999
Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat.
Previous studies by us established that peripheral and hippocampal administration of kappa opioid receptor agonists lowered blood… 
1999
1999
Synergistic centrally mediated cardiovascular effects of a kappa opioid agonist and an alpha2-adrenoceptor agonist.
1994
1994
Effects of naloxone, morphine and κ-opioid receptor agonists on hypoxia/hypoglycemia-induced reduction of 2-deoxyglucose uptake in hippocampal slices from U-50,488H-tolerant rats
1992
1992
Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes
Opioid agonists specific for the μ, δ, and κ opioid receptor subtypes were tested for their ability to modulate potassium-evoked… 
1991
1991
The abilities of specific kappa-opioid agonists, U-50,488H and U-62,066E, to cause antitussive tolerance were lower than that of morphine.
We examined whether the chronic administration of selective kappa-opioid agonists could produce antitussive tolerance, in a… 
1989
1989
Mechanism of diuretic action of U-62,066E, a kappa opioid receptor agonist.
The mechanism of the diuretic action of U-62,066E, a highly selective kappa opioid agonist, was examined in unanesthetized rats… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)